University of Pennsylvania
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Pennsylvania sits in the top decile of US sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count).
University of Pennsylvania: 1,423 sponsored US clinical trials, 199 recruiting.
University of Pennsylvania sponsors 1,423 registered US clinical trials on ClinicalTrials.gov, 199 of them currently recruiting, and 982 completed. 130 of these trials are in Phase 3-4 (later-stage) and 339 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of Pennsylvania ranks in the top decile of sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,423 total, page 23 of 29
A Trial of Behavioral Economic Interventions to Reduce Cardiovascular Disease (CVD) Risk
NCT01346189
24 Hour Intensivist Coverage in the Medical Intensive Care Unit
NCT01434823
Phase I/IIA Study of CART19 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Leukemia and Lymphoma
NCT01626495
Predicting Volume Response Study
NCT01656954
Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant
NCT01426828
Prematurity and Respiratory Outcomes Program (PROP)
NCT01435187
Microparticles in Scuba Divers With Decompression Sickness
NCT01587209
Extubation Readiness Study in Very Low Birthweight Infants
NCT01471431
Endocytoscopy and Colorectal Neoplasia
NCT02324374
Pilot Randomized Control Trial of Financial Incentives for Smoking Cessation
NCT01303081
University Of Pennsylvania Weight Loss Study
NCT01167634
Combination Immunotherapy and Autologous Stem Cell Transplantation for Myeloma
NCT01245673
Autologous Redirected RNA Meso-CIR T Cells
NCT01355965
Melanoma Risk Assessment & Tailored Intervention
NCT01356771
Intraoperative Imaging of Thoracic Malignancies With Indocyanine Green
NCT01335893
Individual Differences in Children's Susceptibility to Overeating
NCT01905293
IMPaCT (Individualized Management Towards Patient-Centered Targets)
NCT01346462
Validation of Instruments for Pragmatic Clinical Trials for Overactive Bladder
NCT01925456
The Effect of a Coloring Prompt on Health Engagement
NCT01352390
Attention & Memory Impairments in Menopausal Women
NCT01324024
Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly
NCT01410799
Congestive Heart Failure Pilot Study Utilizing Wireless Home Scale and Daily Symptom Monitoring
NCT03234088
Relationship Between Changes in Gut Hormones After Gastric Bypass and Gastric Banding and Improvements in Diabetes
NCT01153438
Helping People to Exercise Regularly
NCT01335880
Vacant Lot Greening and Violence-Related Outcomes
NCT01336374
The Impact of Contraception on Postpartum Weight Loss
NCT02144259
Vigabatrin for Cocaine and Alcohol Dependence
NCT01335867
Cognitive Training for Nicotine Dependence
NCT01252966
Encouraging Walking in Older Adults
NCT01282944
Testing Strategies to Encourage Weight Loss in an Employer Setting
NCT01208350
A Trial of Incentives and Peer Mentors to Improve Diabetic Outcomes
NCT01125969
Way to Health, Healthy Measures
NCT01282957
Making Calories Count: Information Format and Food Choice
NCT01346449
Assessing Urinary Hormones in Female Cancer Survivors
NCT03197532
Microvascular Flow Assessment Repeatability Study: The MARS Study
NCT01242020
Efficacy Comparison of Two Preoperative Skin Antisepsis Preparations in Colorectal Surgery
NCT01233050
Pharmacogenetics of Nicotine Addiction Treatment
NCT01314001
Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg Dose
NCT01300988
Neurodegeneration in Newborns After Anesthetics
NCT03064607
Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) Among Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Personnel
NCT01049516
Progesterone and Brain Imaging Study
NCT01954966
Improving Immunogenicity of Influenza Vaccine in HIV Infected Individuals
NCT01262846
A Comparison of Cognitive and Dynamic Therapy for Depression in Community Settings
NCT01207271
Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis
NCT01250990
Effect of Thymoglobulin Versus Basiliximab on Regulatory T Cell Function in Live Donor Kidney Transplant Recipients
NCT02730715
Phenotypic and Genotypic Markers of Performance Vulnerability to Sleep Loss
NCT02130791
Blood Spot Self-administered Test and Assay
NCT03840824
Nicotinic Receptor Levels After Stopping Smoking
NCT01704573
Cardiopulmonary Resuscitation (CPR) Dissemination Study Using Nurses and Volunteers
NCT01252316
Brief Intervention for Problem Drinking and Partner Violence
NCT01207258
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 182 |
| Phase 2 | 157 |
| Phase 3 | 43 |
| Phase 4 | 87 |
Therapeutic Areas
What is open in the University of Pennsylvania pipeline
199 recruiting of 1,423 indexed (14% open); 982 completed (69%).
Phase mix: 130 late (III/IV) vs 339 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.